Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension

Volume: 21, Issue: 17, Pages: 6223 - 6223
Published: Aug 28, 2020
Abstract
Liver cirrhosis is a frequent condition with high impact on patients’ life expectancy and health care systems. Cirrhotic portal hypertension (PH) gradually develops with deteriorating liver function and can lead to life-threatening complications. Other than an increase in intrahepatic flow resistance due to morphological remodeling of the organ, a functional dysregulation of the sinusoids, the smallest functional units of liver vasculature,...
Paper Details
Title
Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension
Published Date
Aug 28, 2020
Volume
21
Issue
17
Pages
6223 - 6223
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.